Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

ConclusionStopping TKIs outside clinical trials is feasible if the guidelines for stopping are followed and an adequate monitoring system is available. Discontinuation of TKIs requires adequate management of anxiety and depression.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research